Cardio Diagnostics Holdings Inc (CDIO)vsInsmed Inc (INSM)
CDIO
Cardio Diagnostics Holdings Inc
$2.14
-4.89%
HEALTHCARE · Cap: $6.78M
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 4091823% more annual revenue ($606.42M vs $14,820). CDIO leads profitability with a 0.0% profit margin vs -2.1%. INSM earns a higher WallStSmart Score of 39/100 (F).
CDIO
Avoid23
out of 100
Grade: F
INSM
Hold39
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
No standout strengths identified
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -78.6% — below average capital efficiency
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : CDIO
The strongest argument for CDIO centers on Price/Book.
Bull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bear Case : CDIO
The primary concerns for CDIO are EPS Growth, Market Cap, Profit Margin.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Key Dynamics to Monitor
CDIO profiles as a value stock while INSM is a turnaround play — different risk/reward profiles.
CDIO carries more volatility with a beta of 2.23 — expect wider price swings.
INSM is growing revenue faster at 1.5% — sustainability is the question.
CDIO generates stronger free cash flow (-1M), providing more financial flexibility.
Bottom Line
INSM scores higher overall (39/100 vs 23/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Cardio Diagnostics Holdings Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Cardio Diagnostics Holdings Inc (CDIO) is a cutting-edge biotechnology company focused on revolutionizing cardiovascular health through its innovative diagnostic solutions. Leveraging advanced technologies, CDIO equips healthcare providers with critical tools for the accurate evaluation and management of cardiovascular diseases, ultimately enhancing patient outcomes. With a strong commitment to personalized medicine, the company is well-positioned for substantial growth, making it an appealing opportunity for institutional investors seeking exposure in a rapidly evolving healthcare sector.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?